Key Market Indicators
Lithuanian Diagnostic Reagent Sales are projected to reach approximately €429 million by 2028, up from €337 million in 2023. This marks an average annual growth rate of 3.8%. Since 2010, the Lithuanian market has experienced an average annual increase of 4.1%. In 2023, Lithuania ranked eighth in this market. Italy led the pack with sales of €337 million, while Spain, the United Kingdom, and Finland occupied the second, third, and fourth spots, respectively. Lithuanian Diagnostic Reagent Exports are expected to hit around $671 million by 2028, rising from $533 million in 2023. This represents an average yearly growth rate of 3.6%. Since 1999, Lithuania's supply of diagnostic reagents has grown at an annual rate of 3.6%. In 2023, Lithuania ranked 13th, with South Korea surpassing it with exports worth $533 million. Germany, the Netherlands, and the United Kingdom held the second, third, and fourth positions, respectively. On the import front, Lithuanian Diagnostic Reagent Imports are anticipated to reach nearly $186 million by 2028, up from $153 million in 2023. This indicates a compound annual growth rate (CAGR) of 3%. Since 1999, Lithuanian demand for diagnostic reagents has increased at an annual rate of 4.5%.
